Literature DB >> 121764

Galactosyltransferase and membrane glycoprotein abnormality in human platelets from Tn-syndrome donors.

J P Cartron, A T Nurden.   

Abstract

Early studies on the analysis of membranes isolated from the erythrocytes of Tn-patients by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) revealed a severe reduction in the staining capacity of glycophorin with the periodate-Schiff (PAS) reaction. A low sialic acid and galactose (Gal) content of the polyagglutinable red cells was confirmed while it was reported that the abnormal red cells of Tn-patients contained little or no UDPGal: GalNAc-beta-3-D-galactosyltransferase (T-transferase) activity. The glycoprotein (GP) abnormality in Tn-erythrocytes appeared to be due to incomplete synthesis of the alkali-labile oligosaccharide chaims of glycophorin. We now report studies on the membrane GP composition and the T-transferase activity of platelets isolated from there Tn-syndrome patients whose red cell membranes contain GP abnormalities which are typical of those found in this rare clinical condition.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 121764     DOI: 10.1038/282621a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  12 in total

1.  Sialylation on O-glycans protects platelets from clearance by liver Kupffer cells.

Authors:  Yun Li; Jianxin Fu; Yun Ling; Tadayuki Yago; J Michael McDaniel; Jianhua Song; Xia Bai; Yuji Kondo; Yannan Qin; Christopher Hoover; Samuel McGee; Bojing Shao; Zhenghui Liu; Roberto Sonon; Parastoo Azadi; Jamey D Marth; Rodger P McEver; Changgeng Ruan; Lijun Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

2.  Constitutively hyposialylated human T-lymphocyte clones in the Tn-syndrome: binding characteristics of plant and animal lectins.

Authors:  K Mrkoci; S Kelm; P R Crocker; R Schauer; E G Berger
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  A novel fluorescent assay for T-synthase activity.

Authors:  Tongzhong Ju; Baoyun Xia; Rajindra P Aryal; Wenyi Wang; Yingchun Wang; Xiaokun Ding; Rongjuan Mi; Miao He; Richard D Cummings
Journal:  Glycobiology       Date:  2010-10-19       Impact factor: 4.313

4.  Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.

Authors:  M Thurnher; S Rusconi; E G Berger
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

5.  Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome.

Authors:  W Vainchenker; G Vinci; U Testa; A Henri; A Tabilio; M P Fache; H Rochant; J P Cartron
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Surface modifications in the platelets of a patient with alpha-N-acetyl-D-galactosamine residues, the Tn-syndrome.

Authors:  A T Nurden; D Dupuis; D Pidard; N Kieffer; T J Kunicki; J P Cartron
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

7.  Evidence for carbohydrate-deficient forms of the major sialoglycoproteins of human platelets, granulocytes and T lymphocytes in individuals with Tn syndrome.

Authors:  P A Judson; F A Spring; M A Taylor; D J Anstee
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

8.  Clonal expression of the Tn antigen in erythroid and granulocyte colonies and its application to determination of the clonality of the human megakaryocyte colony assay.

Authors:  W Vainchenker; U Testa; J F Deschamps; A Henri; M Titeux; J Breton-Gorius; H Rochant; D Lee; J P Cartron
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

9.  Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy.

Authors:  A C Allen; S J Harper; J Feehally
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

Review 10.  The Cosmc connection to the Tn antigen in cancer.

Authors:  Tongzhong Ju; Rajindra P Aryal; Matthew R Kudelka; Yingchun Wang; Richard D Cummings
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.